Holen Sie sich die Stockscreener-App
1.51
1.36%
0.04
Handel nachbörslich:
1.51
Schlusskurs vom Vortag:
$1.47
Offen:
$1.51
24-Stunden-Volumen:
55,220
Relative Volume:
1.15
Marktkapitalisierung:
$8.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.29M
KGV:
-0.3784
EPS:
-3.99
Netto-Cashflow:
$-12.27M
1W Leistung:
+3.47%
1M Leistung:
-3.50%
6M Leistung:
-5.70%
1J Leistung:
-41.80%
1-Tages-Spanne:
$1.473
$1.53
1-Wochen-Bereich:
$1.395
$1.53
52-Wochen-Spanne:
$1.37
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Firmenname
Aprea Therapeutics Inc
Sektor
Branche
Telefon
215-948-4119
Adresse
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Vergleichen Sie APRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.51 | 8.56M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
| 2020-06-22 | Eingeleitet | H.C. Wainwright | Neutral |
| 2020-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2019-10-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aprea Therapeutics Inc Aktie (APRE) Neueste Nachrichten
Aprea Therapeutics Announces Presentations at - GlobeNewswire
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics - Stock Titan
Is Aprea Therapeutics Inc. stock poised for growthJuly 2025 Update & Accurate Intraday Trading Signals - newser.com
Sentiment analysis tools applied to Aprea Therapeutics Inc.Market Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Developing predictive dashboards with Aprea Therapeutics Inc. dataInsider Selling & AI Powered Market Trend Analysis - newser.com
How to recover losses in Aprea Therapeutics Inc. stock2025 Technical Overview & Technical Buy Zone Confirmation - newser.com
Using economic indicators to assess Aprea Therapeutics Inc. potential2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Should you wait for a breakout in Aprea Therapeutics Inc.July 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Aprea Therapeutics (NASDAQ:APRE) Trading Down 3% – Here’s What Happened - Defense World
Historical volatility pattern of Aprea Therapeutics Inc. visualizedPortfolio Growth Summary & Daily Growth Stock Tips - newser.com
Can Aprea Therapeutics Inc. rally from current levelsWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
How sentiment analysis helps forecast Aprea Therapeutics Inc.Market Rally & Free Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-03 04:24:53 - newser.com
How to integrate Aprea Therapeutics Inc. into portfolio analysis toolsJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Reversal indicators forming on Aprea Therapeutics Inc. stockJobs Report & Verified Chart Pattern Signals - newser.com
What analysts say about Aprea Therapeutics Inc stockPrice Support Zones & Low Cost Trading Plans - earlytimes.in
Published on: 2025-09-30 01:07:35 - newser.com
Published on: 2025-09-29 04:10:00 - newser.com
What drives Aprea Therapeutics Inc stock priceTrade Execution Strategies & Big Returns Small Capital - earlytimes.in
Is Aprea Therapeutics Inc a good long term investmentMACD Trading Signals & Rapid Capital Trading Tips - Early Times
Published on: 2025-09-27 17:04:35 - newser.com
Live market analysis of Aprea Therapeutics Inc.2025 Sector Review & Stock Portfolio Risk Control - newser.com
Using portfolio simulators with Aprea Therapeutics Inc. includedJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Aug Gainers: Will Inhibrx Biosciences Inc stock recover after earningsJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - خودرو بانک
Reviewing Aprea Therapeutics (NASDAQ:APRE) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):